| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Puri Raj K. | Chief Regulatory Officer | C/O IOVANCE BIOTHERAPEUTICS, INC., 825 INDUSTRIAL ROAD, SUITE 100, SAN CARLOS | /s/ Raj K. Puri | 04 Jun 2025 | 0002046483 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IOVA | Common Stock | Options Exercise | $0 | +5,469 | +2.6% | $0.000000 | 212,321 | 02 Jun 2025 | Direct | F1 |
| transaction | IOVA | Common Stock | Tax liability | $4,342 | -2,467 | -1.2% | $1.76 | 209,854 | 02 Jun 2025 | Direct | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IOVA | Restricted Stock Units | Options Exercise | $0 | -5,469 | -12% | $0.000000 | 38,287 | 02 Jun 2025 | Common Stock | 5,469 | Direct | F4, F5, F6 |
| Id | Content |
|---|---|
| F1 | Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. |
| F2 | Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. |
| F3 | Represents the common stock remaining after deducting the common stock withheld for taxes. |
| F4 | Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| F5 | The remaining RSUs will vest in equal quarterly installments. |
| F6 | Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. |